---
title: "Acurx Pharmaceuticals (ACXP.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ACXP.US/norm.md"
symbol: "ACXP.US"
name: "Acurx Pharmaceuticals"
parent: "https://longbridge.com/zh-CN/quote/ACXP.US.md"
datetime: "2026-06-13T23:37:38.968Z"
locales:
  - [en](https://longbridge.com/en/quote/ACXP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ACXP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ACXP.US/norm.md)
---

# Acurx Pharmaceuticals (ACXP.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.6200 | -0.7279 | -1.23 | -1.89 | -2.15 |
| ROE | -109.49% | -141.78% | -221.32% | -305.73% | -587.51% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -1.68M | -1.58M | -1.99M | -2.25M | -2.15M |
| 营业利润 | -1.72M | -1.62M | -2.03M | -2.27M | -2.15M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 9.54M | 7.69M | 6.11M | 6.16M | 4.81M |
| 权益乘数 | 1.36 | 1.46 | 1.68 | 1.73 | 2.08 |
| 每股净资产 | 2.07 | 2.24 | 2.02 | 2.43 | 2.06 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 9.25M | 7.56M | 5.91M | 6.06M | 4.64M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | - | - | - | - | - |
| 净债务 | -9.25M | -7.56M | -5.91M | -6.06M | -4.64M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -1.41M | -1.18M | -1.88M | -1.67M | -2.05M |
| 投资现金流 | - | - | - | - | - |
| 融资现金流 | 3.11M | 2.83M | 1.72M | 3.09M | 2.99M |
| 自由现金流 | -1.12M | -617162.00 | -1.20M | -929027.00 | -1.69M |
| 现金流充裕率 | - | - | - | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |